EMT-driven plasticity prospectively increases cell–cell variability to promote therapeutic adaptation in breast cancer
Abstract Cellular plasticity enables cancer cells to adapt non-genetically, thereby preventing therapeutic success. The epithelial-mesenchymal transition (EMT) is a type of plasticity linked to resistance and metastasis. However, its exact impact on population diversity and its dynamics under chemot...
Saved in:
Main Authors: | Lauriane Muller, Frédérique Fauvet, Christelle Chassot, Francesca Angileri, Angèle Coutant, Cyril Dégletagne, Laurie Tonon, Pierre Saintigny, Alain Puisieux, Anne-Pierre Morel, Maria Ouzounova, Pierre Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Cancer Cell International |
Online Access: | https://doi.org/10.1186/s12935-025-03637-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Multifaceted Roles of MicroRNA-181 in Stem Cell Differentiation and Cancer Stem Cell Plasticity
by: Chun Yang, et al.
Published: (2025-01-01) -
Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
by: Chao Wang, et al.
Published: (2025-01-01) -
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
by: Yang Ke, et al.
Published: (2013-01-01) -
Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
by: Renjie Chen, et al.
Published: (2025-01-01) -
Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
by: Junhui Hu, et al.
Published: (2019-01-01)